Peer Responses: Generalized Anxiety Disorder Management During Pregnancy
Responding to Delia Sophia Brand
Hello Delia,
I appreciate your insightful discussion highlighting the thoughtful balance required in the management of Generalized Anxiety Disorder during pregnancy. Your review of sertraline, hydroxyzine, and CBT was thorough and evidence-based. To add on, fluoxetine is another FDA-approved selective serotonin reuptake inhibitor that is frequently used during pregnancy and has been found to be effective and safe. Its longer half-life will reduce the risk of neonatal withdrawal symptoms and thus is a good choice when there is an issue of nonadherence or when symptoms need to be controlled continuously (Sohel et al., 2024). Another effective nonpharmacological alternative to cognitive behavioral therapy is mindfulness-based cognitive therapy (MBCT). MBCT incorporates mindfulness along with cognitive restructuring for preventing the relapse of anxiety and improving emotion regulation. Notably, MBCT is beneficial for reducing prenatal stress and improving maternal well-being (Gkintoni et al., 2025). Offering MBCT may also be appealing to women who want less intensive or more convenient treatment. Overall, your post appropriately emphasized individualized, guideline-driven treatment planning. Great work!
References
Gkintoni, E., Vassilopoulos, S. P., & Nikolaou, G. (2025). Mindfulness-based cognitive therapy in clinical practice: A systematic review of neurocognitive outcomes and applications for mental health and well-being. Journal of Clinical Medicine, 14(5), 1703–1703. https://doi.org/10.3390/jcm14051703
Sohel, A. J., Shutter, M. C., & Molla, M. (2024, February 28). Fluoxetine. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459223/
Response to Dorine Gesare Orucho
Hello Dorine,
Thank you for your thorough and thoughtful review of Generalized Anxiety Disorder management during pregnancy. Your discussion accurately outlines sertraline’s status as the selective serotonin reuptake inhibitor (SSRI) of choice and the newer promise of buspirone. An alternative SSRI for consideration is escitalopram, which, although less studied than sertraline, has been associated with minimal fetal risk and is typically well-tolerated by patients (Landy & Estevez, 2023). For patients who experience side effects with sertraline or fluoxetine, escitalopram is also an option due to its more favorable side effect profile. Regarding psychotherapy, interpersonal therapy (IPT) provides an effective alternative to cognitive behavioral therapy, particularly for pregnant women who are also facing role transition or interpersonal conflict. IPT focuses on building communication skills and resolving social stressors, which can have a significant impact on anxiety symptoms during pregnancy (Weissman, 2020). Conclusively, I appreciate your emphasis on evidence-based practice and patient-centered care, which are essential for optimal maternal and fetal outcomes. Great work.
References
Landy, K., & Estevez, R. (2023). Escitalopram. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557734/
Weissman, M. M. (2020). Interpersonal psychotherapy: History and future. American Journal of Psychotherapy, 73(1), 3–7. https://doi.org/10.1176/appi.psychotherapy.20190032
ORDER A PLAGIARISM-FREE PAPER HERE
We’ll write everything from scratch
Question 
Peer Responses: Generalized Anxiety Disorder Management During Pregnancy
After assessing and diagnosing a patient, PMHNPs must take into consideration special characteristics of the patient before determining an appropriate course of treatment. For pharmacological treatments that are not FDA-approved for a particular use or population, off-label use may be considered when the potential benefits could outweigh the risks.
Generalized Anxiety Disorder Management During Pregnancy
In this Discussion, you will investigate a specific disorder and determine potential appropriate treatments for when it occurs in an older adult or pregnant woman.
RESOURCES
Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources.
WEEKLY RESOURCES
TO PREPARE:
Choose one of the two following specific populations: either pregnant women or older adults. Then, select a specific disorder from the DSM-5-TR to use.
Use the Walden Library to research evidence-based treatments for your selected disorder in your selected population (either older adults or pregnant women). You will need to recommend one FDA-approved drug, one non-FDA-approved “off-label” drug, and one nonpharmacological intervention for treating the disorder in that population.
BY DAY 3 OF WEEK 9
Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating your chosen disorder in older adults or pregnant women.
Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?
Explain whether clinical practice guidelines exist for this disorder, and if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
Support your reasoning with at least three current, credible scholarly resources, one each on the FDA-approved drug, the off-label, and a nonpharmacological intervention for the disorder.
Upload a copy of your discussion writing to the draft Turnitin for plagiarism check. Your faculty holds the academic freedom to not accept your work and grade at a zero if your work is not uploaded as a draft submission to Turnitin as instructed.
Read a selection of your colleagues’ responses.
BY DAY 6 OF WEEK 9
Respond to at least two of your colleagues on 2 different days who selected different disorders. Propose an alternative on-label, off-label, or nonpharmacological treatment for the disorders. Justify your suggestions with at least two references to the literature.